LGND relationship map
LGND
Ligand Pharmaceuticals Inc
LGND sells to Healthcare · 14
AgenusAGEN
2°Zydus LifeSciencesunlisted
2°Zydusunlisted
LeonaBioLONA2°Sermonix Pharmaceuticalsunlisted
2°Shanghai Henlius Biotechunlisted
2°AnswerALS consortiumunlisted
Orchestra BioMedOBIOOvid TherapeuticsOVID2°Northwestern Universityunlisted
2°Marinus Pharmaceuticalsunlisted
2°Healxunlisted
Pelthos TherapeuticsPTHS2°Undisclosed wholesaler customer (35% of gross revenue)unnamed in filing
2°Undisclosed wholesaler customer (35% of 2025 gross revenue)unnamed in filing
2°Undisclosed wholesaler customer (28% of 2025 gross revenue)unnamed in filing
Hovioneunlisted—
← Buys from
LGNDLigand Pharmaceuticals Inc
Healthcare14 · open
AGENAgenus2°Zydus LifeSciencesunlisted
2°Zydusunlisted
AMGNAmgenGILDGileadJAZZJazz Pharmaceuticals2°CNX Therapeuticsunlisted
2°Simtraunlisted
2°AGC Biologics A/Sunlisted
LONALeonaBio2°Sermonix Pharmaceuticalsunlisted
2°Shanghai Henlius Biotechunlisted
2°AnswerALS consortiumunlisted
MRKMerck2°Chongqing Zhifei Biological Productsunlisted
PTHSPelthos Therapeutics2°Undisclosed wholesaler customer (35% of gross revenue)unnamed in filing
2°Undisclosed wholesaler customer (35% of 2025 gross revenue)unnamed in filing
2°Undisclosed wholesaler customer (28% of 2025 gross revenue)unnamed in filing
TVTXTravere2°STA Pharmaceutical Hong Kongunlisted
2°Catalent Pharma Solutionsunlisted
2°PCI Pharma Servicesunlisted
VKTXViking Therapeutics2°Corden Pharma Coloradounlisted
2°Corden Pharma Colorado, Inc. and its affiliates, or CordenPharmaunlisted
2°CBIZ CPAs P.Cunlisted
—Acrotech Biopharmaunlisted
—CASI Pharmaceuticalsunlisted
—Chugai Pharmaceuticalsunlisted
—Travere Therapeuticsunlisted
—Verona Pharmaunlisted
Industrials & materials11 ›Sells to →
2°Zydus LifeSciencesunlisted
2°Zydusunlisted
2°Sermonix Pharmaceuticalsunlisted
2°Shanghai Henlius Biotechunlisted
2°AnswerALS consortiumunlisted
2°Northwestern Universityunlisted
2°Marinus Pharmaceuticalsunlisted
2°Healxunlisted
2°Undisclosed wholesaler customer (35% of gross revenue)unnamed in filing
2°Undisclosed wholesaler customer (35% of 2025 gross revenue)unnamed in filing
2°Undisclosed wholesaler customer (28% of 2025 gross revenue)unnamed in filing
Hovioneunlisted—
← Buys from
LGNDLigand Pharmaceuticals Inc
2°Zydus LifeSciencesunlisted
2°Zydusunlisted
2°CNX Therapeuticsunlisted
2°Simtraunlisted
2°AGC Biologics A/Sunlisted
2°Sermonix Pharmaceuticalsunlisted
2°Shanghai Henlius Biotechunlisted
2°AnswerALS consortiumunlisted
2°Chongqing Zhifei Biological Productsunlisted
2°Undisclosed wholesaler customer (35% of gross revenue)unnamed in filing
2°Undisclosed wholesaler customer (35% of 2025 gross revenue)unnamed in filing
2°Undisclosed wholesaler customer (28% of 2025 gross revenue)unnamed in filing
2°STA Pharmaceutical Hong Kongunlisted
2°Catalent Pharma Solutionsunlisted
2°PCI Pharma Servicesunlisted
2°Corden Pharma Coloradounlisted
2°Corden Pharma Colorado, Inc. and its affiliates, or CordenPharmaunlisted
2°CBIZ CPAs P.Cunlisted
—Acrotech Biopharmaunlisted
—CASI Pharmaceuticalsunlisted
—Chugai Pharmaceuticalsunlisted
—Travere Therapeuticsunlisted
—Verona Pharmaunlisted
Sells to →
suppliercustomerunlisted2°second-degree (Extended)
sector groupThick line = filed share ·Moves · 20:28 ETSources